Post-chemotherapy cognitive impairment

Post-chemotherapy cognitive impairment (PCCI, also known in the scientific community as CRCIs or Chemotherapy-Related Cognitive Impairments" and in lay terms as chemotherapy-induced cognitive dysfunction or impairment, chemo brain, or chemo fog) describes the cognitive impairment that can result from chemotherapy treatment. While there is no concrete statistic for the number of patients that experience some level of post-chemotherapy cognitive impairment, the estimated percentage is between 13 and 70 percent of patients.

Source: Wikipedia — Post-chemotherapy cognitive impairment (CC BY-SA 4.0)